The efficacy and safety of hypertonic citrate as catheter-locking solution in hematopoietic stem cell transplant recipients

Turkiye Klinikleri Cardiovascular Sciences

Volumn 23, Issue 1, 2011, Pages 48-53

  Şahin Balçik, Özlem ^a   Akkaya, Çiǧdem ^b   Uz, Burak ^c   Aksoy, Cafer ^b   Güvenç, Birol ^d   Dinçer, Süleyman ^b  

^a FATIH UNIVERSITY   (Turkey)

^b BAYINDIR HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Catheter related infections; Catheterization; Central venous; Venous thrombosis

Indexed keywords

CALCIUM; CITRATE TRISODIUM; HEPARIN; HYPERTONIC SOLUTION;

ADULT; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EMBOLISM; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERNATREMIA; HYPOCALCEMIA; MALE; THROMBOSIS; TIME;

EID: 79957518927     PISSN: 13067656     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Willicombe MK, Vernon K, Davenport A Embolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solution. Am J Kidney Dis 2010;55(2):348-51.
2. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteremia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 2008;23(5):1666-72. (Pubitemid 351767750)
3. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005;16(9):2769-77.
4. Winnett G, Nolan J, Miller M, Ashman N. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transplant 2008;23(11):3592-8.
5. Hendrickx L, Kuypers D, Evenepoel P, Maes B, Messiaen T, Vanrenterghem Y. A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. Int J Artif Organs 2001;24(4):208-11. (Pubitemid 32479378)
6. Martín-Peña A, Aguilar-Guisado M, Espigado I, Parody R, Miguel Cisneros J. Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients. Clin Transplant 2010 May 10. doi:10.1111/j.1399-0012.2010.01286.x.
7. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002;13(8):2133-9. (Pubitemid 34790791)
8. Gagnon RF, Harris AD, Prentis J, Richards GK. The effects of heparin on rifampin activity against Staphylococcus epidermidis biofilms. Adv Perit Dial 1989;5:138-42.
9. Bosma JW, Siegert CE, Peerbooms PG, Weijmer MC. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial. Nephrol Dial Transplant 2010;25(4):1213-7.
10. Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull CC, Velasquez KA, et al. Concentrated sodium citrate (23%) for catheter lock. Hemodial Int 2000;4(1):22-31.
11. Stas KJ, Vanwalleghem J, De Moor B, Keuleers H. Trisodium citrate 30% vs. heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis. Nephrol Dial Transplant 2001;16(7):1521-2. (Pubitemid 32640629)
12. Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002;17(12): 2189-95.
13. Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 2008;21(4):385-92.
14. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP. Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 1988;32(11):1627-31. (Pubitemid 18267605)
15. Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006;21(8):2247-55. (Pubitemid 44295052)
16. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, et al. Substantial reduction of infectious complications in hemodialysis patients with trisodium citrate 30% as catheter locking solution; a prospective multicenter double-blind randomised controlled trial. [abstract] Am Soc Nephrol 2003;14:54
17. Dittmer ID, Sharp D, McNulty CA, Williams AJ, Banks RA. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 1999;51(1):34-9. (Pubitemid 29027404)
18. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms, a common cause of persistent infections. Science 1999;284(5418):1318-22. (Pubitemid 29289651)
19. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987;41:435-64.
20. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors. Nephron Clin Pract 2007;107(4):c128-32.
21. Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 1991;37:91-105.
22. Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Crit Care Med 1992;20(5):665-73.
23. Tenney JH, Moody MR, Newman KA, Schimpff SC, Wade JC, Costerton JW, et al. Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med 1986;146(10):1949-54.
24. Hoyle BD, Alcantara J, Costerton JW. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob Agents Chemother 1992;36(9):2054-6.
25. Buturović J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 1998;22(11):945-7.
26. Bayes B, Bonal J, Romero R. Sodium citrate for filling haemodialysis catheters. Nephrol Dial Transplant 1999;14(10):2532-3. (Pubitemid 29462517)
27. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM. Trisodium citrate 4% - an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007;22(2):477-83.
28. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters - an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 2007;22(2):471-6. (Pubitemid 46189891)
29. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003;36(12):1539-44. (Pubitemid 36783336)
30. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004;19(6):1546-51. (Pubitemid 38786749)
31. Plamondon I, Agharazii EA, Langlois S, Desmeules S. Randomized cross-over comparison of 4% citrate and heparin for catheter lock of double lumen haemodialysis catheters (abstract). J Am Soc Nephrol 2005;16:12A.
32. Punt CD, Boer WE. Cardiac arrest following injection of concentrated trisodium citrate. Clin Nephrol 2008;69(4):317-8. (Pubitemid 351516280)
33. Uhl L, Maillet S, King S, Kruskall MS. Unexpected citrate toxicity and severe hypocalcemia during apheresis. Transfusion 1997;37(10):1063-5. (Pubitemid 27459593)
34. Davis TM, Singh B, Choo KE, Ibrahim J, Spencer JL, St John A. Dynamic assessment of the electrocardiographic QT interval during citrate infusion in healthy volunteers. Br Heart J 1995;73(6):523-6.
35. Doorenbos CJ, Van den Elsen-Hutten M, Heuven MJ, Hessels J. Estimation of trisodium citrate (Citra-Lock) remaining in central venous catheters after the interdialytic interval. Nephrol Dial Transplant 2006;21(2):543-5.
36. Srivastava R, Murphy MJ, Card J, Severn A, Fraser CG. The case of the floating gel. J Clin Pathol 2004;57(12):1333-4. (Pubitemid 39611525)